Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 22857526)

1.

Blocking pathogen entry into the cell: the future of infectious disease treatment and control?

Steinkamp HM, Satoskar AR.

Future Med Chem. 2012 Jul;4(11):1375-7. doi: 10.4155/fmc.12.91. No abstract available.

PMID:
22857526
2.

Current world literature.

[No authors listed]

Curr Opin Infect Dis. 2010 Jun;23(3):275-91. doi: 10.1097/QCO.0b013e32833a9f8a. No abstract available.

PMID:
20407317
3.

Development of novel entry inhibitors targeting emerging viruses.

Zhou Y, Simmons G.

Expert Rev Anti Infect Ther. 2012 Oct;10(10):1129-38. doi: 10.1586/eri.12.104. Review.

4.

Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications.

Bartlett AH, Park PW.

Expert Rev Mol Med. 2010 Feb 1;12:e5. doi: 10.1017/S1462399409001367. Review.

PMID:
20113533
5.

Management of infectious diseases.

Grayson ML, Wesselingh S.

Med J Aust. 2002 Mar 4;176(5):202-3. No abstract available.

PMID:
11999232
6.

Infectious disease management for Aboriginal children of Far West NSW.

Gough N, Oates S, Grillet S, Pholeros P.

N S W Public Health Bull. 2013 Nov;24(2):95. doi: 10.1071/NB12120. No abstract available.

7.

Immunomodulatory approaches for prevention and treatment of infectious diseases.

Nijnik A.

Curr Opin Microbiol. 2013 Oct;16(5):590-5. doi: 10.1016/j.mib.2013.06.011. Epub 2013 Jul 17. Review.

PMID:
23870826
8.

Screening of small-molecule compounds as inhibitors of HCV entry.

Yang JP, Zhou D, Wong-Staal F.

Methods Mol Biol. 2009;510:295-304. doi: 10.1007/978-1-59745-394-3_22.

PMID:
19009270
9.

Designing tomorrow's vaccines.

Nabel GJ.

N Engl J Med. 2013 Feb 7;368(6):551-60. doi: 10.1056/NEJMra1204186. Review. No abstract available.

10.

Montpellier infectious diseases (MID): 1st annual meeting (2011).

Sitbon M, Biard-Piechaczyk M, Robert V, Briant L, Köhler S, Labesse G, Devaux C.

Infect Genet Evol. 2011 Oct;11(7):1493-8. doi: 10.1016/j.meegid.2011.07.001. Epub 2011 Jul 13. No abstract available.

PMID:
21767666
11.

Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.

Mittapalli GK, Jackson A, Zhao F, Lee H, Chow S, McKelvy J, Wong-Staal F, Macdonald JE.

Bioorg Med Chem Lett. 2011 Nov 15;21(22):6852-5. doi: 10.1016/j.bmcl.2011.09.019. Epub 2011 Sep 16.

PMID:
21978675
13.

Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture.

Coburn GA, Fisch DN, Moorji SM, de Muys JM, Murga JD, Paul D, Provoncha KP, Rotshteyn Y, Han AQ, Qian D, Maddon PJ, Olson WC.

PLoS One. 2012;7(4):e35351. doi: 10.1371/journal.pone.0035351. Epub 2012 Apr 24.

14.

Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.

Sourisseau M, Michta ML, Zony C, Israelow B, Hopcraft SE, Narbus CM, Parra Martín A, Evans MJ.

PLoS Pathog. 2013 Mar;9(3):e1003244. doi: 10.1371/journal.ppat.1003244. Epub 2013 Mar 21.

15.

Between microbial attack and defence: the endothelium as a vulnerable player in infectious diseases.

Schnittler H, Preissner KT.

Thromb Haemost. 2009 Dec;102(6):1011-3. doi: 10.1160/TH09-11-0760. No abstract available.

PMID:
19967129
16.

Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.

Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.

Hepatology. 2012 Aug;56(2):484-91. doi: 10.1002/hep.25665. Epub 2012 Jul 2.

17.

A novel small molecule inhibitor of hepatitis C virus entry.

Baldick CJ, Wichroski MJ, Pendri A, Walsh AW, Fang J, Mazzucco CE, Pokornowski KA, Rose RE, Eggers BJ, Hsu M, Zhai W, Zhai G, Gerritz SW, Poss MA, Meanwell NA, Cockett MI, Tenney DJ.

PLoS Pathog. 2010 Sep 2;6(9):e1001086. doi: 10.1371/journal.ppat.1001086.

18.

Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms.

Adedeji AO, Severson W, Jonsson C, Singh K, Weiss SR, Sarafianos SG.

J Virol. 2013 Jul;87(14):8017-28. doi: 10.1128/JVI.00998-13. Epub 2013 May 15.

19.

Burden of infectious diseases in South Asia.

Zaidi AK, Awasthi S, deSilva HJ.

BMJ. 2004 Apr 3;328(7443):811-5. Review. No abstract available.

20.

Host-directed drug targeting of factors hijacked by pathogens.

Schwegmann A, Brombacher F.

Sci Signal. 2008 Jul 22;1(29):re8. doi: 10.1126/scisignal.129re8. Review.

PMID:
18648074
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk